Moderator's view: Ambulatory blood pressure monitoring and home blood pressure for the prognosis, diagnosis and treatment of hypertension in dialysis patients

Nephrology Dialysis Transplantation

Volumn 30, Issue 9, 2015, Pages 1443-1448

  Zoccali, Carmine ^a   Tripepi, Rocco ^a   Torino, Claudia ^a   Tripepi, Giovanni ^a   Mallamaci, Francesca ^a,b  

^a CNR   (Italy)

^b Nephrology Dialysis and Renal Transplantation Unit   (Italy)

Author keywords

ABPM; dialysis; ESRD; home BP; hypertension

Indexed keywords

CARVEDILOL; TELMISARTAN;

AREA UNDER THE CURVE; BLOOD PRESSURE MONITORING; COST EFFECTIVENESS ANALYSIS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOME MONITORING; HUMAN; HYPERTENSION; KIDNEY DISEASE; LIFE EXPECTANCY; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SYSTOLIC HYPERTENSION; BLOOD PRESSURE; PHYSIOLOGY; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; HUMANS; HYPERTENSION; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84940655252     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv241     Document Type: Review

References (40)

1. Agarwal R, Peixoto AJ, Santos SF et al. Pre-and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol 2006; 1: 389-398
2. Zoccali C, BeneDetto FA, Mallamaci F et al. Left ventricular hypertrophy and nocturnal hypoxemia in hemodialysis patients. J Hypertens 2001; 19: 287-293
3. Agarwal R, Sinha AD, Light RP. Toward a Definition of masked hypertension and white-coat hypertension among hemodialysis patients. Clin J Am Soc Nephrol 2011; 6: 2003-2008
4. McManus RJ, Caulfield M,Williams B. NICE hypertension guiDeline 2011: eviDence based evolution. BMJ 2012; 344: e181
5. Parati G, Stergiou G, O'Brien E et al. European Society of Hypertension practice guiDelines for ambulatory blood pressure monitoring. J Hypertens 2014; 32: 1359-1366
6. Piper MA, EVans CV, BurDa BU et al. Diagnostic and predictive accuracy of blood pressure screening methods with consiDeration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2015; 162: 192-204
7. Agarwal R. Blood pressure and mortality among hemodialysis patients. Hypertension 2010; 55: 762-768
8. Alborzi P, Patel N, Agarwal R. Home blood pressures are of greater prognostic value than hemodialysis unit recordings. Clin J Am Soc Nephrol 2007; 2: 1228-1234
9. Pepe MS, Janes H, Longton G et al. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker.AmJ EpiDemiol 2004; 159: 882-890
10. Degoulet P, Legrain M, Reach I et al. Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron 1982; 31: 103-110
11. Kalantar-ZaDeh K, Kilpatrick RD, McAllister CJ et al. Reverse epiDemiology of hypertension and cardiovascular Death in the hemodialysis population: the 58th annual fall conference and scientific sessions. Hypertension 2005; 45: 811-817
12. Brown EA, Johansson L. Dialysis options for end-stage renal disease in olDer people. Nephron Clin Pract 2011; 119 (Suppl 1): c10-c13
13. Jardine A. ABPM in patients receiving haemodialysis: a sore arm and a waste of time Nephrol Dial Transplant 2015
14. Parfrey PS, Foley RN, Harnett JD et al. Outcome and risk factors for left ventricular disorDers in chronic uraemia. Nephrol Dial Transplant 1996; 11: 1277-1285
15. Floege J, Gillespie IA, Kronenberg F et al. Development and valiDation of a predictive mortality risk score from a European hemodialysis cohort. Kidney Int 2015; 87: 996-1008
16. Patel A, MacMahon S, Chalmers J et al. Effects of a fixed combination of perindopril and inDapamiDe on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (theADVANCEtrial): a randomised controlled trial. Lancet 2007; 370: 829-840
17. Sundstrom J, Arima H, Woodward M et al. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient Data. Lancet 2014; 384: 591-598
18. Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet 2000; 356: 147-152
19. Bansal N, McCulloch CE, Rahman M et al. Blood pressure and risk of allcause mortality in adVanced chronic kidney disease and hemodialysis: the chronic renal insufficiency cohort study. Hypertension 2015; 65: 93-100
20. Cice G, Ferrara L,D'Andrea Aet al. Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebocontrolled trial. J Am Coll Cardiol 2003; 41: 1438-1444
21. Cice G, Di BeneDetto A, D'Isa S et al. Effects of telmisartan adDed to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebocontrolled trial. J Am Coll Cardiol 2010; 56: 1701-1708
22. Agarwal R. Ambulatory blood pressure should be used in all patients on hemodialysis. Nephrol Dial Transplant 2015
23. Agarwal R, AnDersen MJ, Bishu K et al. Home blood pressure monitoring improves the diagnosis of hypertension in hemodialysis patients. Kidney Int 2006; 69: 900-906
24. Agarwal R. The controversies of diagnosing and treating hypertension among hemodialysis patients. Semin Dial 2012; 25: 370-376
25. Agarwal R, Satyan S, Alborzi P et al. Home blood pressure measurements for managing hypertension in hemodialysis patients. Am J Nephrol 2009; 30: 126-134
26. Zhang L, Li Y, Wei FF et al. Strategies for classifying patients based on office, home, and ambulatory blood pressure measurement. Hypertension 2015; 65: 1258-1265
27. Hodgkinson J, Mant J, Martin U et al. Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ 2011; 342: d3621
28. Agarwal R. How should hypertension be assessed and managed in hemodialysis patients Home BP, not dialysis unit BP, should be used for managing hypertension. Semin Dial 2007; 20: 402-405
29. Giles TD. Apathy towards ambulatory blood pressure monitoring use in hypertension: is it due to cognitive dissonance, money, or both Hypertension 2015; 65: 1156-1157
30. The Clinical Management of Primary Hypertension in Adults. Methods, EviDence and RecommenDations. National Clinical GuiDeline Centre 2011
31. Agarwal R, Martinez-Castelao A,Wiecek A et al. The lingering dilemma of arterial pressure in CKD: what do we know, where do we go Kidney Int Suppl (2011) 2011; 1: 17-20
32. AbDel-KaDer K, Unruh ML, Weisbord SD. Symptom burDen, Depression, and quality of life in chronic and end-stage kidney disease. Clin J Am Soc Nephrol 2009; 4: 1057-1064
33. Agarwal R, Light RP. Chronobiology of arterial hypertension in hemodialysis patients: implications for home blood pressure monitoring.AmJ Kidney Dis 2009; 54: 693-701
34. Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis 2007; 14: 82-99
35. Weisbord SD, Fried LF, Mor MK et al. Renal proviDer recognition of symptoms in patients on maintenance hemodialysis. Clin J Am Soc Nephrol 2007; 2: 960-967
36. Little P, Barnett J, Barnsley L et al. Comparison of acceptability of and preferences for different methods of measuring blood pressure in primary care. BMJ 2002; 325: 258-259
37. Margolis KL, Asche SE, BergDall AR et al. A successful multifaceted trial to improve hypertension control in primary care: why did it work J Gen Intern Med 2015; doi: 10.1007/s11606-015-3355-x
38. Cappuccio FP, Kerry SM, Forbes L et al. Blood pressure control by home monitoring: meta-analysis of randomised trials. BMJ 2004; 329: 145
39. Da Silva GV, De Barros S, Abensur H et al. Home blood pressure monitoring in blood pressure control among haemodialysis patients: an open randomized clinical trial. Nephrol Dial Transplant 2009; 24: 3805-3811
40. Margolis KL, Asche SE, BergDall AR et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA 2013; 310: 46-56